Vantrexa · NSCLC · Japan · Thoracic medical oncologist · captured by Rachel Adeyemi on 28 Jan 2026 · reviewed by Dr. Elena Moretti on 29 Jan 2026
Verbatim as captured; never edited
Thoracic medical oncologist at Osaka University Hospital raised brain-metastasis subgroup data during a scientific exchange. They noted that colleagues in their network share the view.
Human-approved by Dr. Elena Moretti on 29 Jan 2026
Brain-metastasis subgroup data: request for data reported by thoracic medical oncologist (JP).
No AI assistance
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 2 | 20% | 8.0 |
| Strategic alignment | 1 | 20% | 4.0 |
| Scientific importance | 1 | 15% | 3.0 |
| Urgency | 3 | 15% | 9.0 |
| Novelty | 4 | 10% | 8.0 |
| Actionability | 1 | 10% | 2.0 |
| Confidence | 3 | 5% | 3.0 |
| Breadth of occurrence | 3 | 5% | 3.0 |
| Total | Low 40 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
26 Jan 2026 · Dr. Yuki Quinn, Osaka University Hospital · MSL Rachel Adeyemi
Insight
Reviewed 29 Jan 2026 by Dr. Elena Moretti
Action
Publication project · David Chen · In progress
Decision
Outcome
Closure